Latest Channelopathy Stories
MARIETTA, Ga., Oct. 29 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. today announced that Amanda Rudd has been awarded the title of 2009 Thriving Student Achiever for her creative entry expressing her dream for the future.
Electronic eye implanted at NewYork-Presbyterian Hospital/Columbia mimics human retina.
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases.
The most common gene for a syndrome associated with abnormal heart rhythms and sudden death triggers epileptic seizures and could explain sudden unexplained death in epilepsy, said researchers from Baylor College of Medicine in a report that appears today in the journal Science Translational Medicine.
A multi-national research team has discovered that two genetic factors converge to increase the risk of sudden cardiac death.
PARSIPPANY, N.J., Sept. 28 /PRNewswire/ -- JHP Pharmaceuticals, LLC ("JHP") announced today that it had developed, and received approval by the FDA for DantriumÂ® IV (dantrolene sodium for injection), a rapidly mixing product.
Genes previously known to be essential to the coordinated, rhythmic electrical activity of cardiac muscle -- a healthy heartbeat -- have now also been found to play a key role in thyroid hormone (TH) biosynthesis, according to Weill Cornell Medical College researchers.
A South Jersey man says his eyesight is returning, weeks after doctors at Wills Eye Institute in Philadelphia implanted electrodes behind his left eye. Michael Adler, 49, began losing his sight as a child, The Philadelphia Inquirer reported Tuesday.
Seven applicants receive a total of over $1.7 million BERWYN, Pa., July 28 /PRNewswire-USNewswire/ -- The NephCure Foundation (NCF) has awarded more than $1.7 million to researchers in its 2009 Scientific Research Grant Program.
Using a common cold virus to deliver a corrected gene to cystic fibrosis cells restores normal function to lung tissue, researchers in North Carolina said. The treatment is the most efficient gene therapy for cystic fibrosis to be found in the last 20 years, researchers at the University of North Carolina said Tuesday in a release. The next step is to ensure the safety of the delivery system so it can be administered to cystic fibrosis patients, who suffer from thicker-than-normal mucus that...
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.